17-20451492-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001367292.2(LGALS9B):āc.913C>Gā(p.Gln305Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000459 in 1,524,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001367292.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGALS9B | ENST00000423676.8 | c.913C>G | p.Gln305Glu | missense_variant | Exon 10 of 11 | 1 | NM_001367292.2 | ENSP00000388841.3 | ||
LGALS9B | ENST00000324290.5 | c.910C>G | p.Gln304Glu | missense_variant | Exon 10 of 11 | 5 | ENSP00000315564.5 | |||
LGALS9B | ENST00000578481.5 | n.*713C>G | non_coding_transcript_exon_variant | Exon 9 of 10 | 2 | ENSP00000464627.1 | ||||
LGALS9B | ENST00000578481.5 | n.*713C>G | 3_prime_UTR_variant | Exon 9 of 10 | 2 | ENSP00000464627.1 |
Frequencies
GnomAD3 genomes AF: 0.0000115 AC: 1AN: 87022Hom.: 0 Cov.: 11
GnomAD3 exomes AF: 0.0000343 AC: 7AN: 204140Hom.: 0 AF XY: 0.0000449 AC XY: 5AN XY: 111280
GnomAD4 exome AF: 0.00000417 AC: 6AN: 1437872Hom.: 0 Cov.: 30 AF XY: 0.00000700 AC XY: 5AN XY: 714606
GnomAD4 genome AF: 0.0000115 AC: 1AN: 87022Hom.: 0 Cov.: 11 AF XY: 0.0000244 AC XY: 1AN XY: 40964
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.910C>G (p.Q304E) alteration is located in exon 10 (coding exon 10) of the LGALS9B gene. This alteration results from a C to G substitution at nucleotide position 910, causing the glutamine (Q) at amino acid position 304 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at